Copyright Reports & Markets. All rights reserved.

Global Acute Intermittent Porphyria Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Acute Intermittent Porphyria Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Acute Intermittent Porphyria Therapeutics
      • 1.2 Acute Intermittent Porphyria Therapeutics Segment by Type
        • 1.2.1 Global Acute Intermittent Porphyria Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 350mg
        • 1.2.3 313mg
      • 1.3 Acute Intermittent Porphyria Therapeutics Segment by Application
        • 1.3.1 Acute Intermittent Porphyria Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Pharmacy
      • 1.4 Global Acute Intermittent Porphyria Therapeutics Market by Region
        • 1.4.1 Global Acute Intermittent Porphyria Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Acute Intermittent Porphyria Therapeutics Market Size
        • 1.5.1 Global Acute Intermittent Porphyria Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Acute Intermittent Porphyria Therapeutics Production (2014-2025)

      2 Global Acute Intermittent Porphyria Therapeutics Market Competition by Manufacturers

      • 2.1 Global Acute Intermittent Porphyria Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Acute Intermittent Porphyria Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Acute Intermittent Porphyria Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Acute Intermittent Porphyria Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Acute Intermittent Porphyria Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Acute Intermittent Porphyria Therapeutics Market Concentration Rate
        • 2.5.2 Acute Intermittent Porphyria Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Acute Intermittent Porphyria Therapeutics Production Market Share by Regions

      • 3.1 Global Acute Intermittent Porphyria Therapeutics Production Market Share by Regions
      • 3.2 Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Acute Intermittent Porphyria Therapeutics Production
        • 3.4.1 North America Acute Intermittent Porphyria Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Acute Intermittent Porphyria Therapeutics Production
        • 3.5.1 Europe Acute Intermittent Porphyria Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Acute Intermittent Porphyria Therapeutics Production (2014-2019)
        • 3.6.1 China Acute Intermittent Porphyria Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Acute Intermittent Porphyria Therapeutics Production (2014-2019)
        • 3.7.1 Japan Acute Intermittent Porphyria Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Acute Intermittent Porphyria Therapeutics Consumption by Regions

      • 4.1 Global Acute Intermittent Porphyria Therapeutics Consumption by Regions
      • 4.2 North America Acute Intermittent Porphyria Therapeutics Consumption (2014-2019)
      • 4.3 Europe Acute Intermittent Porphyria Therapeutics Consumption (2014-2019)
      • 4.4 China Acute Intermittent Porphyria Therapeutics Consumption (2014-2019)
      • 4.5 Japan Acute Intermittent Porphyria Therapeutics Consumption (2014-2019)

      5 Global Acute Intermittent Porphyria Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Acute Intermittent Porphyria Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Acute Intermittent Porphyria Therapeutics Price by Type (2014-2019)
      • 5.4 Global Acute Intermittent Porphyria Therapeutics Production Growth by Type (2014-2019)

      6 Global Acute Intermittent Porphyria Therapeutics Market Analysis by Applications

      • 6.1 Global Acute Intermittent Porphyria Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Acute Intermittent Porphyria Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Acute Intermittent Porphyria Therapeutics Business

      • 7.1 Abbott
        • 7.1.1 Abbott Acute Intermittent Porphyria Therapeutics Production Sites and Area Served
        • 7.1.2 Acute Intermittent Porphyria Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Abbott Acute Intermittent Porphyria Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served

      8 Acute Intermittent Porphyria Therapeutics Manufacturing Cost Analysis

      • 8.1 Acute Intermittent Porphyria Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Acute Intermittent Porphyria Therapeutics
      • 8.4 Acute Intermittent Porphyria Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Acute Intermittent Porphyria Therapeutics Distributors List
      • 9.3 Acute Intermittent Porphyria Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Acute Intermittent Porphyria Therapeutics Market Forecast

      • 11.1 Global Acute Intermittent Porphyria Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Acute Intermittent Porphyria Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Acute Intermittent Porphyria Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Acute Intermittent Porphyria Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Acute Intermittent Porphyria Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Acute Intermittent Porphyria Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Acute Intermittent Porphyria Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Acute Intermittent Porphyria Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Acute Intermittent Porphyria Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Acute Intermittent Porphyria Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Acute Intermittent Porphyria Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Acute Intermittent Porphyria Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Acute Intermittent Porphyria Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Acute Intermittent Porphyria Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Acute Intermittent Porphyria Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Acute Intermittent Porphyria Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.

        The global Acute Intermittent Porphyria Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Acute Intermittent Porphyria Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Intermittent Porphyria Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbott
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        350mg
        313mg

        Segment by Application
        Hospital
        Pharmacy

        Buy now